Short communication: Low expression of activation and inhibitory molecules on NK cells and CD4+ T cells is associated with viral control

AIDS Research and Human Retroviruses

Volumn 31, Issue 6, 2015, Pages 636-640

  Taborda, Natalia A ^a   Hernández, Juan C ^b   Lajoie, Julie ^c   Juno, Jennifer A ^c   Kimani, Joshua ^c,d   Rugeles, María T ^a   Fowke, Keith R ^c,d  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^b UNIVERSIDAD COOPERATIVA DE COLOMBIA   (Colombia)

^c UNIVERSITY OF MANITOBA   (Canada)

^d UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; LYMPHOCYTE ACTIVATION GENE 3 PROTEIN; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN; PROTEIN TIM 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

APOPTOSIS; ARTICLE; BLOOD LEVEL; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS EXPOSED SERONEGATIVE INDIVIDUAL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFLAMMATION; LOW RISK POPULATION; LYMPHOCYTE ACTIVATION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERODIAGNOSIS; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION; ADULT; BLOOD; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; YOUNG ADULT;

ADULT; BIOMARKERS; CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; CYTOKINES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84930240290     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2014.0325     Document Type: Article

References (46)

1. Piacentini L, Fenizia C, Naddeo V, et al.: Not just sheer luck! Immune correlates of protection against HIV-1 infection. Vaccine 2008;26(24):3002-3007.
2. Baker BM, Block BL, Rothchild AC, et al.: Elite control of HIV infection: Implications for vaccine design. Expert Opin Biol Ther 2009;9(1):55-69.
3. Koning F, Otto S, Hazenberg MD, et al.: Low-level CD4 + T cell activation is associated with low susceptibility to HIV-1 infection. J Immunol 2005;175(9):6117-6122.
4. Card CM, Rutherford WJ, Ramdahin S, et al.: Reduced cellular susceptibility to in vitro HIV infection is associated with CD4 + T cell quiescence. PloS One 2012;7(9):e45911.
5. Card CM, Ball TB, and Fowke KR: Immune quiescence: A model of protection against HIV infection. Retrovirology 2013;10(1):141.
6. Alimonti JB, Koesters S, Kimani J, et al.: CD4 + T cell responses in HIV-exposed seronegative women are qualitatively distinct from those in HIV-infected women. J Infect Dis 2005;191(1):20-24.
7. Chen H, Li C, Huang J, et al.: CD4 + T cells from elite controllers resist HIV-1 infection by selective upregulation of p21. J Clin Invest 2011;121(4):1549-1560.
8. Singla A: Increased activity of NK cells and plasmacytoid dendritic cells in HIV-exposed seronegative (ESN) individuals. World J AIDS 2012;02(01):6-16.
9. Marras F, Nicco E, Bozzano F, et al.: Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation. Proc Natl Acad Sci USA 2013;110:11970-11975.
10. Brenchley JM, Price D, Schacker TW, et al.: Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nature Med 2006;12(12):1365-1371.
11. Noel N, Boufassa F, Lécuroux C, et al.: Elevated IP10 levels are associated with immune activation and low CD4+ T-cell counts in HIV controller patients. AIDS 2014;28(4):467-476.
12. Norris PJ, Pappalardo BL, Custer B, et al.: Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV type 1 infection. AIDS Res Hum Retroviruses 2006; 22(8):757-762.
13. Asquith B, Edwards CTT, Lipsitch M, et al.: Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo. PLoS Biol 2006;4(4):e90.
14. Parsons MS, Wren L, Isitman G, et al.: HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity. J Virol 2012;86(8):4488-4495.
15. Khaitan A and Unutmaz D: Revisiting immune exhaustion during HIV infection. Curr HIV/AIDS Rep 2011;8(1):4-11.
16. Wong AHW, Williams K, Reddy S, et al.: Alterations in natural killer cell receptor profiles during HIV type 1 disease progression among chronically infected South African adults. AIDS Res Hum Retroviruses 2010;26(4):459-469.
17. Lajoie J, Kimani M, Plummer F, et al.: Association of sex work with reduced activation of the mucosal immune system. J Infect Dis 2014;210(2):319-329.
18. Zapata W, Aguilar-Jiménez W, Pineda-Trujillo N, et al.: Influence of CCR5 and CCR2 genetic variants in the resistance/susceptibility to HIV in serodiscordant couples from Colombia. AIDS Res Hum Retroviruses 2013;29(12): 1594-1603.
19. Velilla PA, Hoyos A, Rojas M, et al.: Apoptosis as a mechanism of natural resistance to HIV-1 infection in an exposed but uninfected population. J Clin Virol 2005;32(4): 329-335.
20. Zapata W, Rodriguez B, Weber J, et al.: Increased levels of human beta-defensinsmRNAin sexually HIV-1 exposed but uninfected individuals. Curr HIV Res 2008;6(6):531-538.
21. Clerici M, Barassi C, Devito C, et al.: Serum IgA of HIVexposed uninfected individuals inhibit HIV through recognition of a region within the alpha-helix of gp41. AIDS 2002;16(13):1731-1741.
22. Hladik F, Liu H, Speelmon E, et al.: Combined effect of CCR5-delta32 heterozygosity and the CCR5 promoter polymorphism-2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission. J Virol 2005;79(18):11677-11684.
23. Montoya CJ, Velilla PA, Chougnet C, et al.: Increased IFNgamma production by NK and CD3 +/CD56 + cells in sexually HIV-1-exposed but uninfected individuals. Clin Immunol 2006;120(2):138-146.
24. Lajoie J, Juno J, Burgener A, et al.: A distinct cytokine and chemokine profile at the genital mucosa is associated with HIV-1 protection among HIV-exposed seronegative commercial sex workers. Mucosal Immunol 2012;5(3):277-287.
25. Koning FA, Otto SA, Hazenberg MD, et al.: Low-level CD4 + T cell activation is associated with low susceptibility to HIV-1 infection. J Immunol 2005;175(9):6117-6122.
26. Bégaud E, Chartier L, Marechal V, et al.: Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans. Retrovirology 2006;3:35.
27. McLaren PJ, Ball TB, Wachihi C, et al.: HIV-exposed seronegative commercial sex workers show a quiescent phenotype in the CD4 + T cell compartment and reduced expression of HIV-dependent host factors. J Infect Dis 2010;202(Suppl):S339-344.
28. Songok EM, Luo M, Liang B, et al.: Microarray analysis of HIV resistant female sex workers reveal a gene expression signature pattern reminiscent of a lowered immune activation state. PloS One 2012;7(1):e30048.
29. Meier A, Bagchi A, Sidhu HK, et al.: Upregulation of PDL1 on monocytes and dendritic cells by HIV-1 derived TLR ligands. AIDS 2008;22(5):655-658.
30. Che KF, Sabado RL, Shankar EM, et al.: HIV-1 impairs in vitro priming of naïve T cells and gives rise to contactdependent suppressor T cells. Eur J Immunol 2010;40(8): 2248-2258.
31. Zhang G, Liu Z,Duan S, et al.: Association of polymorphisms of programmed cell death-1 gene with chronic hepatitis B virus infection. Hum Immunol 2010;71(12):1209-1213.
32. Li Z, Li N, Zhu Q, et al.: Genetic variations of PD1 and TIM3 are differentially and interactively associated with the development of cirrhosis and HCC in patients with chronic HBV infection. Infect Genet Evol 2013;14:240-246.
33. Duan S, Zhang G, Han Q, et al.: CTLA-4 exon 1 + 49 polymorphism alone and in a haplotype with-318 promoter polymorphism may confer susceptibility to chronic HBV infection in Chinese Han patients. Mol Biol Rep 2011; 38(8):5125-5132.
34. Sironi M, Biasin M, Gnudi F, et al.: A regulatory polymorphism in HAVCR2 modulates susceptibility to HIV-1 infection. PloS One 2014;9(9):e106442.
35. Ndhlovu LC, Lopez-verge S, Barbour JD, et al.: Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity. Blood 2012;119(16):3734-3743.
36. Hazenberg MD, Otto S, van Benthem BHB, et al.: Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 2003;17(13):1881-1888.
37. Zhang J-Y, Zhang Z, Wang X, et al.: PD-1 up-regulation is correlated with HIV-specific memory CD8 + T-cell exhaustion in typical progressors but not in long-term nonprogressors. Blood 2007;109(11):4671-4678.
38. Leng Q, Bentwich Z, Magen E, et al.: CTLA-4 upregulation during HIV infection: Association with anergy and possible target for therapeutic intervention. AIDS 2002; 16(4):519-529.
39. Day CL, Kaufmann DE, Kiepiela P, et al.: PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006;443(7109):350-354.
40. Jones RB, Ndhlovu LC, Barbour JD, et al.: Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med 2008;205(12):2763-2779.
41. Price P, Keane N, Gray L, et al.: CXCR4 or CCR5 tropism of human immunodeficiency virus type 1 isolates does not determine the immunological milieu in patients responding to antiretroviral therapy. Viral Immunol 2006;19(4): 734-740.
42. Williams LD, Bansal A, Sabbaj S, et al.: Interleukin-21-producing HIV-1-specific CD8 T cells are preferentially seen in elite controllers. J Virol 2011;85(5):2316-2324.
43. Hersperger AR, Pereyra F, Nason M, et al.: Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control. PLoS Pathog 2010;6(5): e1000917.
44. Tiemessen CT, Shalekoff S, Meddows-Taylor S, et al.: Natural killer cells that respond to human immunodeficiency virus type 1 (HIV-1) peptides are associated with control of HIV-1 infection. J Infect Dis 2010;202(9):1444-1453.
45. Pereyra F, Palmer S, Miura T, et al.: Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters. J Infect Dis 2009;200(6):984-990.
46. Taborda NA, Catanõ JC, Delgado JC, et al.: Higher SLPI expression, lower immune activation, and increased frequency of immune cells in a cohort of Colombian HIV-1 controllers. J Acquir Immune Defic Syndr 2012;60(1): 12-19.